The following provides information about the Ontario Ministry of Health and Long-Term Care's (the ministry's) Universal Influenza Immunization Program (UIIP) for the 2015/2016 season. The official launch of the 2015/2016 UIIP is October 26, 2015. As in previous years, high priority groups should be immunized first, followed by the general public. The high priority groups include: persons at high risk of influenza-related complications or more likely to require hospitalization and persons capable of transmitting influenza to those at high risk, as outlined below.
The following individuals are eligible and recommended for the publicly funded influenza vaccine in Ontario (provided that they have no contraindications to the vaccine):
In addition, the ministry strongly recommends that swine and poultry industry workers receive influenza immunization as early as possible.
|Agriflu® / Fluviral®||Influvac®||Fluad®||FluLaval Tetra® / Fluzone Quadrivalent®||Flumist® Quadrivalent|
|Influenza Vaccine Formulation||Trivalent inactivated vaccine (TIV)||Trivalent inactivated vaccine (TIV)||Trivalent inactivated vaccine (adjuvanted) (TIV-adjuvanted)||Quadrivalent inactivated vaccine (QIV)||Quadrivalent live attenuated vaccine (Q-LAIV)|
|Dosage||0.5mL||0.5mL||0.5mL||0.5mL||0.2mL (0.1mL in each nostril)|
|Route of Administration||Intramuscular Injection||Intramuscular Injection||Intramuscular Injection||Intramuscular Injection||Intranasal spray|
(see "Vaccines for Specific Age Groups" below)
|6 months and older*||18 years and older||65 years and older who reside in long-term care homes||6 months through 17 years||2 through 17 years; preferred vaccine for 2 through 5 years|
|Potential Allergens||Agriflu: Egg protein^
|Package Description||Multi-dose vial||Single dose syringe||Single dose syringe||Multi-dose vial||Single dose sprayer|
|Once punctured, discard vial after||28 days||n/a||n/a||FluLaval:
expiry date indicated on vial
|Package Dimensions (length x width x height)||3cm x 3cm x 7cm||18.8cm x 15.2cm x 1.7cm||10.8cm x 10.2cm x 4.4cm||3cm x 3cm x 6cm||10.6cm x 17.6cm x 2.9cm|
* Unless specifically requested the TIVs are primarily targeted to adults 18 years of age and older.
^ Egg allergy is not a contraindication to receiving inactivated influenza vaccines (see National Advisory Committee on Immunization Influenza Statement www.phac-aspc.gc.ca/naci-ccni/flu-grippe-eng.php)
|Age Group||Recommended Vaccine||Alternative Vaccine|
|6 through 23 months||QIV||TIV§ (if requested or if QIV is not available)|
|2 through 5 years||Q-LAIV|| QIV (if requested or if Q-LAIV is not available)
TIV§ (if requested or if QIV is not available)
|6 through 17 years||QIV or Q-LAIV||TIV§ (if requested or if QIV / Q-LAIV is not available)|
|18 years and older||TIV||None|
|65 years and older who reside in long-term care homes||TIV-adjuvanted||TIV (if requested or if TIV-adjuvanted is not available)|
§ Only Agriflu® and Fluviral® can be used to immunize individuals under 18 years of age.
|Providers that have been approved to participate in the UIIP that are located||Order vaccine directly from vaccine supply source|
| outside Toronto
(not within the "M" area code)
|Local public health unit by using the Influenza Vaccine Order Form for the UIIP|
| within Toronto
(within the "M" area code)
|Ontario Government Pharmaceutical and Medical Supply Service (OGPMSS) by faxing the Influenza Vaccine Order Form for the UIIP to 416-327-0818|
The TIV products (Agriflu®, Influvac®, and Fluviral®) and the QIV vaccine products (FluLaval Tetra® and Fluzone Quadrivalent®) will be distributed based on availability (with the exception of FluMist, requests for specific TIV products or QIV products are not permitted). Each TIV product and each QIV product are considered equivalent with respect to their approved indications for use. Please consult your local public health unit to determine vaccine availability for your clinic.
Prior to October 26, as the vaccine will be available for high risk individuals, vaccine orders will be filled primarily for facilities that care for, and/or immunize, high priority groups, including long-term care homes, public hospitals, physicians' offices, and health unit clinics that are held specifically for persons in the high priority groups.
During the week of October 19th onward, vaccine orders will start being filled more generally for health care providers including pharmacies, health care agencies, workplaces, etc. to prepare them for the administration of influenza vaccine to the general population.
All required fields of the Influenza Vaccine Order Form for the UIIP must be completed to ensure orders are filled.
Please Note: Vaccine wastage due to spoilage or expiry is a concern for all immunization programs, including the influenza program. The Vaccine Storage and Handling Guidelines have been developed to facilitate proper storage and handling of publicly funded vaccines and minimize vaccine wastage as well as promote vaccine safety and efficacy.
When minimum cold chain requirements are not met by a health care provider, the public health unit has the authority to withhold vaccines until compliance issues have been resolved or until completion of other follow-up deemed necessary to ensure appropriate vaccine storage and handling. For health care providers who order vaccines directly from the OGPMSS, the board of health shall instruct the OGPMSS to discontinue further vaccine deliveries to the health care provider premises until the requirements have been met.
To view Portable Document Format PDF files, you will need to have Adobe Acrobat® Reader installed on your computer. You can download this free software from the Adobe website.
Please e-mail email@example.com or call Service Ontario, INFOline at 1 877-844-1944